Marketed Products

A Strong Portfolio of Commercial Products

At Fortress Biotech, we leverage our extensive biopharmaceutical business expertise, drug development capabilities and connections with our esteemed partners to develop and commercialize various pharmaceutical products. Through our partner company, Journey Medical Corporation, we currently market a variety of dermatology products.

Logo for

Ximino®

Ximino® is the first and only extended-release minocycline with Capsular Minotab Technology indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older.

Learn More About Ximino®
Logo for

Targadox®

Targadox® is a 50 mg immediate-release doxycycline hyclate coated tablet that is indicated as adjunctive therapy for severe acne.

Learn More About Targadox®
Logo for

Exelderm®

Exelderm® is an antifungal agent available as both a cream and solution.

Exelderm® Cream 1.0% is an antifungal agent indicated for the treatment of tinea pedis (athlete’s foot), tinea cruris, and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagro-phytes, Epidermophyton floccosum, and Microsporum canis,* and for the treatment of tinea versicolor.
*Efficacy for this organism in the organ system was studied in fewer than 10 infections.

Exelderm® Solution 1.0% is a broad-spectrum antifungal agent indicated for the treatment of tinea cruris and tinea corporis caused by Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, and Microsporum canis; and for the treatment of tinea versicolor. Effectiveness has not been proven in tinea pedis (athlete’s foot).

Learn More About Exelderm®
Logo for

Ceracade®

Ceracade® is formulated for the treatment of dry skin conditions and to manage and relieve the burning and itching associated with various types of dermatitis.

Learn More About Ceracade®
Logo for

Luxamend®

Luxamend® wound cream is a water-based emulsion formulated for the treatment of superficial wounds, minor abrasions, dermal ulcers, donor sites, first- and second-degree burns, and radiation dermatitis.

Learn More About Luxamend®